Invesco Pharmaceuticals ETF PJP
126.78 USD +0.32 (+0.25%)
At closeNov 6, 2026, 4:00 PM EST
126.78 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
124.54 Day range 127.31
96.90 52-week range 131.64
- YTD
- +21.27%
- 1 year
- +30.23%
News
zacks.com Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on…
benzinga.com What's Going On With Amgen Stock Tuesday? AMGN stock dips 9% after rival drug trial misses goal. Discover Amgen key support levels, technical outlook, and analyst price targets
benzinga.com Two Years to Build or Pay 200% — Which US Pharma Stocks Win? Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.
benzinga.com Amgen Posts 77% Response In Thyroid Eye Disease Study Amgen shares fall despite Phase 3 TEPEZZA OBI data showing 77% response rate and proptosis reduction in thyroid eye disease patients.
benzinga.com Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial Pfizer's Braftovi combo improves survival in advanced colorectal cancer trial.
benzinga.com Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
benzinga.com Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."
benzinga.com Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
benzinga.com Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
benzinga.com Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.
benzinga.com Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' Barclays has said that it's hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.
benzinga.com Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
benzinga.com Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
benzinga.com Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
benzinga.com Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency' Trump vows to slash drug prices with new executive order, potentially dropping them by 30-80%.
benzinga.com Trump Administration Considers Lowering US Drug Prices To International Levels: Report The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations.
benzinga.com Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
benzinga.com FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.- benzinga.com FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
benzinga.com COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected by Sept.
benzinga.com Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI) 
benzinga.com The Definitive Biotech ETF Guide (IBB, XBI, FBT) 
benzinga.com Viva Vivus, But Not In ETFs (VVUS, IBB, PJP) - benzinga.com Twelve Health Care ETFs Trading Near 52-Week Highs